Testing effectiveness (Phase 2)WithdrawnNCT00021307
What this trial is testing
Temozolomide Plus Carboplatin in Treating Patients With Recurrent Glioblastoma Multiforme
Who this might be right for
Brain and Central Nervous System Tumors
Fox Chase Cancer Center